<?xml version="1.0" encoding="UTF-8" standalone="no"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://purl.org/rss/1.0/modules/prism/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"> <channel rdf:about="http://www.bmj.com"> <title>Latest headlines from BMJ</title> <link>http://www.bmj.com</link> <description></description> <prism:eIssn>1756-1833</prism:eIssn> <prism:publicationName>BMJ</prism:publicationName> <items> <rdf:Seq> <rdf:li rdf:resource="http://www.bmj.com/content/388/bmj.r187.short?rss=1"/> <rdf:li rdf:resource="http://www.bmj.com/content/388/bmj.r183.short?rss=1"/> <rdf:li rdf:resource="http://www.bmj.com/content/388/bmj-2023-077515.short?rss=1"/> <rdf:li rdf:resource="http://www.bmj.com/content/388/bmj.r21.short?rss=1"/> <rdf:li rdf:resource="http://www.bmj.com/content/388/bmj.r180.short?rss=1"/> <rdf:li rdf:resource="http://www.bmj.com/content/388/bmj.r178.short?rss=1"/> </rdf:Seq> </items> <image rdf:resource="http://www.bmj.com/icons/site/logo.bmj.gif"/> <xhtml:meta content="noindex" name="robots" xmlns:xhtml="http://www.w3.org/1999/xhtml"/></channel> <image rdf:about="http://www.bmj.com/icons/site/logo.bmj.gif"> <title>BMJ</title> <url>http://www.bmj.com/icons/site/logo.bmj.gif</url> <link>http://www.bmj.com</link> </image> <item rdf:about="http://www.bmj.com/content/388/bmj.r187.short?rss=1"> <title><![CDATA[Gambling: Asking patients at checkups will reduce harms, says NICE]]></title> <link>http://www.bmj.com/content/388/bmj.r187.short?rss=1</link> <description><![CDATA[GPs and other healthcare professionals should ask patients about gambling during routine checkups and ensure access to early effective help for those at high risk of gambling harms, the National Institute for Health and Care Excellence has said in its first clinical guidance on dealing with harms related to gambling.1NICE said its recommendations could lead to effective early identification and treatment that may reduce the number of people experiencing longer term or more serious harm from gambling, saving money for the NHS and the criminal justice system. Experts said that the guidance would bring a unified approach to tackling problems that wreck many people’s health, finances, and relationships and are estimated to be linked to hundreds of suicides a year.Liz Ritchie, who cofounded the charity Gambling with Lives with her husband, Charles, after the gambling related suicide of their son Jack and who was part of the NICE committee that...]]></description> <dc:creator><![CDATA[Matthew Limb]]></dc:creator> <dc:date>2025-01-28T03:41:13-08:00</dc:date> <dc:identifier>info:doi/10.1136/bmj.r187</dc:identifier> <dc:identifier>hwp:master-id:bmj;bmj.r187</dc:identifier> <dc:publisher>BMJ Publishing Group Ltd</dc:publisher> <dc:subject><![CDATA[General practice / family medicine]]></dc:subject> <dc:title><![CDATA[Gambling: Asking patients at checkups will reduce harms, says NICE]]></dc:title> <prism:publicationDate>2025-01-28</prism:publicationDate> <prism:section>News</prism:section> <prism:volume>388</prism:volume> <prism:issueIdentifier>jan28_6</prism:issueIdentifier> </item> <item rdf:about="http://www.bmj.com/content/388/bmj.r183.short?rss=1"> <title><![CDATA[Midwifery conference criticised for repeatedly accepting formula milk sponsorship]]></title> <link>http://www.bmj.com/content/388/bmj.r183.short?rss=1</link> <description><![CDATA[The British Journal of Midwifery’s annual conference is again being sponsored by formula milk companies, despite clinicians and nutritionists repeatedly raising concerns about the practice which flouts World Health Organization guidance.The conference, set to take place on 27 March in London, is being sponsored by two formula milk companies—Kendamil and Nutricia—with Kendamil also given a sponsored session slot.1 Last year’s conference was criticised over its sponsorship by Aptamil, Kendamil, and Nestlé.2WHO has cautioned healthcare professionals and their associations against accepting funding from commercial formula milk companies as it may undermine their “scientific credibility” and “cause reputational harm.”“There is compelling evidence that aggressive marketing by manufacturers and distributors of commercial milk formula adversely impacts infant and young child feeding practices,” WHO guidance has said.3 “Companies that market foods for infants and young children should not sponsor meetings of health professionals and scientific meetings.”Katie Pereira-Kotze, senior nutritionist at the charity First Steps...]]></description> <dc:creator><![CDATA[Elisabeth Mahase]]></dc:creator> <dc:date>2025-01-28T03:01:20-08:00</dc:date> <dc:identifier>info:doi/10.1136/bmj.r183</dc:identifier> <dc:identifier>hwp:master-id:bmj;bmj.r183</dc:identifier> <dc:publisher>BMJ Publishing Group Ltd</dc:publisher> <dc:title><![CDATA[Midwifery conference criticised for repeatedly accepting formula milk sponsorship]]></dc:title> <prism:publicationDate>2025-01-28</prism:publicationDate> <prism:section>News</prism:section> <prism:volume>388</prism:volume> <prism:issueIdentifier>jan28_5</prism:issueIdentifier> </item> <item rdf:about="http://www.bmj.com/content/388/bmj-2023-077515.short?rss=1"> <title><![CDATA[Adolescent menstrual health must go beyond pads]]></title> <link>http://www.bmj.com/content/388/bmj-2023-077515.short?rss=1</link> <description><![CDATA[Menstruation and the menstrual cycle affect female health and wellbeing from menarche, the first menstrual period, to menopause.123 Adolescent girls and women worldwide consistently report negative experiences with menstruation, including missed or delayed diagnosis of menstrual disorders. These issues have far reaching consequences for their wellbeing, education, livelihood opportunities, empowerment, and overall health.456 Investment in menstrual health (box 1) during adolescence is increasingly recognised as a pathway to mitigate these consequences and address gender inequality. This was emphasised in 2022 when the World Health Organization declared menstrual health as a health and human rights issue and not solely a hygiene issue.8 The emerging concept of menstrual justice highlights how harmful power structures and social norms result in menstrual related discrimination in many spheres of life that impede menstrual health.9Box 1Main components of menstrual health7Menstrual health is a state of complete physical, mental, and social wellbeing, not merely the absence of...]]></description> <dc:creator><![CDATA[Marni Sommer, Julie Hennegan, Arundati Muralidharan, Caroline W Kabiru, Therese Mahon, Penelope A Phillips-Howard]]></dc:creator> <dc:date>2025-01-28T02:26:07-08:00</dc:date> <dc:identifier>info:doi/10.1136/bmj-2023-077515</dc:identifier> <dc:identifier>hwp:master-id:bmj;bmj-2023-077515</dc:identifier> <dc:publisher>BMJ Publishing Group Ltd</dc:publisher> <dc:title><![CDATA[Adolescent menstrual health must go beyond pads]]></dc:title> <prism:publicationDate>2025-01-28</prism:publicationDate> <prism:section>Analysis</prism:section> <prism:volume>388</prism:volume> <prism:issueIdentifier>jan28_4</prism:issueIdentifier> </item> <item rdf:about="http://www.bmj.com/content/388/bmj.r21.short?rss=1"> <title><![CDATA[Ghana&#x2019;s physician assistants demand greater autonomy amid rising tensions]]></title> <link>http://www.bmj.com/content/388/bmj.r21.short?rss=1</link> <description><![CDATA[“Disappointed chameleons.” That’s how Frank Serebour, president of the Ghana Medical Association, reportedly referred to physician assistants (PAs). His comments sparked calls for his resignation in 2022.1 This sharp rhetoric has stoked tensions, fuelling perceptions of an elitist and ego driven divide in Ghana’s healthcare system.In 2023 the Medical and Dental Council (MDC) de-accredited more than half of Ghana’s university PA training programmes, leading to accusations of professional gatekeeping—particularly since reasons for the de-accreditations were never made public. The BMJ asked the MDC for comment, but did not receive a reply.“About 10 universities were running a PA programme prior to that action by the MDC. Now we have only about five, or maybe fewer than that,” says Joel Padi, secretary general of the West African Association of Physician Assistants (WAAPA). Others say that attempts have been made to restrict PAs’ scope of practice—which is unrealistic when PAs form a central...]]></description> <dc:creator><![CDATA[Yemisi Bokinni]]></dc:creator> <dc:date>2025-01-28T02:26:46-08:00</dc:date> <dc:identifier>info:doi/10.1136/bmj.r21</dc:identifier> <dc:identifier>hwp:master-id:bmj;bmj.r21</dc:identifier> <dc:publisher>BMJ Publishing Group Ltd</dc:publisher> <dc:title><![CDATA[Ghana&#x2019;s physician assistants demand greater autonomy amid rising tensions]]></dc:title> <prism:publicationDate>2025-01-28</prism:publicationDate> <prism:section>Feature</prism:section> <prism:subsection1>Features</prism:subsection1> <prism:volume>388</prism:volume> <prism:issueIdentifier>jan28_3</prism:issueIdentifier> </item> <item rdf:about="http://www.bmj.com/content/388/bmj.r180.short?rss=1"> <title><![CDATA[Serious failings in NHS complaints system leaves patients reluctant to speak out, says patient watchdog]]></title> <link>http://www.bmj.com/content/388/bmj.r180.short?rss=1</link> <description><![CDATA[Nearly a quarter (24%) of people in England experienced poor NHS care in the past year, but only 9% of those affected lodged a formal complaint, according to the patient watchdog Healthwatch England.1In a survey of a nationally representative sample of 2042 adults conducted by YouGov, the watchdog found that 24% reported they’d had a poor experience of NHS care in the past 12 months. This would scale up to 10.7 million adults across the population having negative NHS interactions.To understand in more detail what actions people take if they feel let down by the NHS, YouGov boosted the initial polling sample to 2650 people who’d experienced poor care in the past year. Most (56%) took no action about their experience. Some (30%) gave feedback to the service, either verbally to staff members; raised the matter with the Patient Advice and Liaison Service; filed it in a patient survey; or...]]></description> <dc:creator><![CDATA[Brian Kennedy]]></dc:creator> <dc:date>2025-01-28T01:51:13-08:00</dc:date> <dc:identifier>info:doi/10.1136/bmj.r180</dc:identifier> <dc:identifier>hwp:master-id:bmj;bmj.r180</dc:identifier> <dc:publisher>BMJ Publishing Group Ltd</dc:publisher> <dc:title><![CDATA[Serious failings in NHS complaints system leaves patients reluctant to speak out, says patient watchdog]]></dc:title> <prism:publicationDate>2025-01-28</prism:publicationDate> <prism:section>News</prism:section> <prism:volume>388</prism:volume> <prism:issueIdentifier>jan28_2</prism:issueIdentifier> </item> <item rdf:about="http://www.bmj.com/content/388/bmj.r178.short?rss=1"> <title><![CDATA[Researchers call for UK Sunshine Act as Novo Nordisk is again reprimanded over undisclosed payments]]></title> <link>http://www.bmj.com/content/388/bmj.r178.short?rss=1</link> <description><![CDATA[The Danish drug giant Novo Nordisk, known for its antidiabetes and weight loss drugs such as semaglutide (Ozempic or Wegovy), has been censured by the UK’s Prescription Medicines Code of Practice Authority (PMCPA) over its failure to properly disclose payments to healthcare organisations and patients’ groups between 2015 and 2022.It is the third time in less than a year that the PMCPA, the self-regulatory body that administers the code of practice of the Association of the British Pharmaceutical Industry (ABPI),1 has reprimanded the company over this issue. Experts in research transparency have said that the repeated offences make a mockery of self-regulation of the drug industry and that only a law to disclose payments backed by financial penalties will deter companies from inappropriate marketing.In July last year Novo Nordisk voluntarily admitted that it had failed to disclose around 500 payments totalling £7.8m to 150 recipients, including doctors, patients, journalists, and...]]></description> <dc:creator><![CDATA[Elisabeth Mahase]]></dc:creator> <dc:date>2025-01-28T01:31:15-08:00</dc:date> <dc:identifier>info:doi/10.1136/bmj.r178</dc:identifier> <dc:identifier>hwp:master-id:bmj;bmj.r178</dc:identifier> <dc:publisher>BMJ Publishing Group Ltd</dc:publisher> <dc:title><![CDATA[Researchers call for UK Sunshine Act as Novo Nordisk is again reprimanded over undisclosed payments]]></dc:title> <prism:publicationDate>2025-01-28</prism:publicationDate> <prism:section>News</prism:section> <prism:volume>388</prism:volume> <prism:issueIdentifier>jan28_1</prism:issueIdentifier> </item> </rdf:RDF>